A new study has revealed that the gene HMGN1 is a key driver of congenital heart defects (CHDs) in Down syndrome. Using ...
Can artificial intelligence function as a partner in scientific discovery, capable of generating novel, testable hypotheses ...
Advances in cancer immunotherapy from immune checkpoint modulation to adoptive cell transfer of tumour-infiltrating ...
BEVs carry diverse molecular cargo that offers non-invasive biomarkers for early diagnosis and monitoring of PCOS and ...
India Today on MSN
Shot in the arm for Indian drugmakers as US FDA moves to ease biosimilar approvals
A proposed move by the US Food and Drug Administration (FDA) to accelerate development and ease approval of biosimilars could ...
After examining the evolutionary history of fungi, an international group of scientists has concluded that these organisms first appeared between 900 ...
Professor Lindsay J Hall explains how introducing probiotics into neonatal care can help combat antimicrobial resistance in ...
The global Phage MuA Transposase Market is entering a dynamic phase of expansion, offering transformative opportunities for ...
In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...
Liver cells are indispensable for research—for drug testing, to better understand diseases such as hepatitis, fatty liver, cirrhosis, or liver cancer and for development of future cell therapies.
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback